Why should we back?
Intro
Welcome to KickstartNew! Today we’re highlighting an innovative health and wellness gadget now on Kickstarter: MATELASER W1 REGEN, an ultra-light wearable red light therapy device designed to bring clinic-grade deep tissue laser therapy into everyday life. This portable solution aims to help people manage recovery, circulation, and pain without bulky equipment or expensive clinical visits.

Why should I back this project?
-
Medical-level laser therapy in a tiny form – At just 24g, W1 REGEN is one of the lightest wearable laser devices, offering powerful photobiomodulation that can penetrate deep into muscles and joints.
-
Portable and affordable – Priced around $99, it breaks cost barriers for professional-grade therapy and can be used at home, gym, or on the go.
-
Dual-wavelength effectiveness – Combines red and near-infrared light to target both surface circulation and deeper tissue recovery.
-
Broad user appeal – Designed for athletes, people with chronic tension, post-surgical recovery, or aging-related discomfort.
What are the potential drawbacks you should consider when you back it?
-
Therapy results vary – Individual responses to light therapy differ, and benefits may not be immediate or guaranteed for every user.
-
Scientific nuance – While photobiomodulation shows promise, results depend heavily on usage patterns and condition severity.
-
Learning and consistency – Users need to learn optimal placement and treatment duration to see benefits.
-
Privacy of health claims – Expectations around medical outcomes should be realistic, not viewed as a replacement for professional treatment.

The reliability of the project
-
FDA-certified manufacturer – The team behind W1 REGEN is an established laser therapy hardware maker with FDA certification, lending credibility to the product’s safety and design.
-
Innovative laser engineering – Uses patented VCSEL laser architecture and dual wavelengths aimed at deeper tissue penetration than typical LED devices.
-
Early interest from experts – Featured at prominent bio-optimization events, where professionals showed early support for its potential.




